BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26373411)

  • 1. Ductal Carcinoma In Situ: Treatment Update and Current Trends.
    Mitchell KB; Kuerer H
    Curr Oncol Rep; 2015 Nov; 17(11):48. PubMed ID: 26373411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
    Punglia RS; Schnitt SJ; Weeks JC
    J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates in the treatment of ductal carcinoma in situ of the breast.
    Lebeau A; Kühn T
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):49-58. PubMed ID: 26694830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
    Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
    Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.
    Kane RL; Virnig BA; Shamliyan T; Wang SY; Tuttle TM; Wilt TJ
    J Natl Cancer Inst Monogr; 2010; 2010(41):130-3. PubMed ID: 20956816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K
    Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal carcinoma in situ.
    Bleicher RJ
    Surg Clin North Am; 2013 Apr; 93(2):393-410. PubMed ID: 23464692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast conserving treatment for ductal carcinoma in situ in the elderly: can radiation therapy be avoided? Our experience.
    Falco G; Rocco N; Procaccini E; Sommella MG; Bordoni D; Cenini E; Castagnetti F; Sabatino V; Compagna R; Della Corte GA; Accurso A; Amato B; Ferrari G
    Int J Surg; 2014; 12 Suppl 2():S47-S49. PubMed ID: 25167849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACR appropriateness criteria(®) ductal carcinoma in situ.
    Moran MS; Bai HX; Harris EE; Arthur DW; Bailey L; Bellon JR; Carey L; Goyal S; Halyard MY; Horst KC; MacDonald SM; Haffty BG;
    Breast J; 2012; 18(1):8-15. PubMed ID: 22107336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Trends in the Management of Ductal Carcinoma In Situ.
    Park TS; Hwang ES
    Oncology (Williston Park); 2016 Sep; 30(9):823-31. PubMed ID: 27633413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in the Treatment of Ductal Carcinoma in Situ.
    Barrio AV; Van Zee KJ
    Annu Rev Med; 2017 Jan; 68():197-211. PubMed ID: 28099081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective.
    Newman LA
    J Natl Cancer Inst Monogr; 2010; 2010(41):152-7. PubMed ID: 20956822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ--management update.
    Stuart K; Boyages J; Brennan M; Ung O
    Aust Fam Physician; 2005 Nov; 34(11):949-54. PubMed ID: 16299630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
    Martínez-Pérez C; Turnbull AK; Ekatah GE; Arthur LM; Sims AH; Thomas JS; Dixon JM
    Cancer Treat Rev; 2017 Apr; 55():163-172. PubMed ID: 28402908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box.
    Lazzeroni M; Dunn BK; Pruneri G; Jereczek-Fossa BA; Orecchia R; Bonanni B; DeCensi A
    Cancer Treat Rev; 2017 Apr; 55():1-9. PubMed ID: 28262606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine Therapy for Ductal Carcinoma In Situ (DCIS) of the Breast with Breast Conserving Surgery (BCS) and Radiotherapy (RT): a Meta-Analysis.
    Yan Y; Zhang L; Tan L; Ma X; Zhang Y; Shao S; Liu J; Xue C; Li Z; Zhang X; Drokow EK; Shi X; Ren J
    Pathol Oncol Res; 2020 Jan; 26(1):521-531. PubMed ID: 30499075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.